SYNLAB AG provided earnings guidance for the year 2023. The Group continues to expect revenues of around EUR 2.7 billion in Fiscal Year 2023 considering the sale of the operations in Switzerland, the operations in Poland and Ukraine as well as the veterinary diagnostics business in Belgium, Germany, and Spain with an overall anticipated contribution to revenue generation of around EUR 38 million in Fourth Quarter 2023.